Harding TC - Search Results

1

K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.

Smith BD, Kasamon YL, Kowalski J, Gocke C, Murphy K, Miller CB, Garrett-Mayer E, Tsai HL, Qin L, Chia C, Biedrzycki B, Harding TC, Tu GH, Jones R, Hege K, Levitsky HI. Smith BD, et al. Among authors: harding tc. Clin Cancer Res. 2010 Jan 1;16(1):338-47. doi: 10.1158/1078-0432.CCR-09-2046. Clin Cancer Res. 2010. PMID: 20048335 Free PMC article. Clinical Trial.

2

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.

Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K. Li B, et al. Among authors: harding tc. Clin Cancer Res. 2006 Nov 15;12(22):6808-16. doi: 10.1158/1078-0432.CCR-06-1558. Clin Cancer Res. 2006. PMID: 17121902

3

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.

van den Eertwegh AJ, Versluis J, van den Berg HP, Santegoets SJ, van Moorselaar RJ, van der Sluis TM, Gall HE, Harding TC, Jooss K, Lowy I, Pinedo HM, Scheper RJ, Stam AG, von Blomberg BM, de Gruijl TD, Hege K, Sacks N, Gerritsen WR. van den Eertwegh AJ, et al. Among authors: harding tc. Lancet Oncol. 2012 May;13(5):509-17. doi: 10.1016/S1470-2045(12)70007-4. Epub 2012 Feb 10. Lancet Oncol. 2012. PMID: 22326922

4

Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy.

Nguyen MC, Tu GH, Koprivnikar KE, Gonzalez-Edick M, Jooss KU, Harding TC. Nguyen MC, et al. Among authors: harding tc. Cancer Immunol Immunother. 2010 Sep;59(9):1313-23. doi: 10.1007/s00262-010-0858-5. Epub 2010 May 25. Cancer Immunol Immunother. 2010. PMID: 20499060 Free PMC article.

5

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.

He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K. He Y, et al. Cancer Res. 2005 Jun 1;65(11):4739-46. doi: 10.1158/0008-5472.CAN-04-4576. Cancer Res. 2005. PMID: 15930292

6

Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.

Lin J, Lalani AS, Harding TC, Gonzalez M, Wu WW, Luan B, Tu GH, Koprivnikar K, VanRoey MJ, He Y, Alitalo K, Jooss K. Lin J, et al. Among authors: harding tc. Cancer Res. 2005 Aug 1;65(15):6901-9. doi: 10.1158/0008-5472.CAN-05-0408. Cancer Res. 2005. PMID: 16061674

7

AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma.

Harding TC, Lalani AS, Roberts BN, Yendluri S, Luan B, Koprivnikar KE, Gonzalez-Edick M, Huan-Tu G, Musterer R, VanRoey MJ, Ozawa T, LeCouter RA, Deen D, Dickinson PJ, Jooss K. Harding TC, et al. Mol Ther. 2006 May;13(5):956-66. doi: 10.1016/j.ymthe.2006.02.004. Epub 2006 Mar 31. Mol Ther. 2006. PMID: 16580881 Free article.

8

Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.

Robinson M, Li B, Ge Y, Ko D, Yendluri S, Harding T, VanRoey M, Spindler KR, Jooss K. Robinson M, et al. J Virol. 2009 Apr;83(8):3450-62. doi: 10.1128/JVI.02561-08. Epub 2009 Feb 4. J Virol. 2009. PMID: 19193803 Free PMC article.

9

Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.

Harding TC, Dickinson PJ, Roberts BN, Yendluri S, Gonzalez-Edick M, Lecouteur RA, Jooss KU. Harding TC, et al. Hum Gene Ther. 2006 Aug;17(8):807-20. doi: 10.1089/hum.2006.17.807. Hum Gene Ther. 2006. PMID: 16942441

10

Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer.

Nguyen M, Huan-Tu G, Gonzalez-Edick M, Rivera VM, Clackson T, Jooss KU, Harding TC. Nguyen M, et al. Among authors: harding tc. Mol Ther. 2007 May;15(5):912-20. doi: 10.1038/mt.sj.6300079. Epub 2007 Jan 23. Mol Ther. 2007. PMID: 17245354 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters